Mohannad Ashtar

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

I. Endo, Toshio Matsumoto, T. Haneji, 2020, Haematologica.

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ

M. Abe, A. Oda, K. Udaka, 2019, Oncotarget.

Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA

S. Yoshida, Kiyoe Kurahashi, I. Endo, 2018, British journal of haematology.

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat

I. Endo, Toshio Matsumoto, K. Tanimoto, 2020, Cancers.

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression

I. Endo, H. Sakaue, Toshio Matsumoto, 2022, Clinical & translational immunology.

Hemifacial Microsomia Caused by First and Second Brachial Arch Syndrome Treated with Orthodontic Approach: A Case Report.

E. Tanaka, M. Hiasa, Keiichiro Watanabe, 2020, The journal of contemporary dental practice.